Area of research
Infectious Diseases · Virology
Research interest
Research interests include HIV Research and Treatment, HIV/AIDS drug development and treatment, HIV-related health complications and treatments, and HIV/AIDS Research and Interventions.
Chinese HIV Controllers Exhibit Different Immunophenotypic Profiles and Viral Reservoir Dynamics Compared to Normal Progressors: A Real-World Cohort Study.
Single-cell multi-omics profiling uncovers the immune heterogeneity in HIV-infected immunological non-responders
Exploring distinct modes of inter-spike cross-linking for enhanced neutralization by SARS-CoV-2 antibodies.
Comprehensive transcriptomic analyses identify the immunosuppressive effects of LLDT-8 in ART-treated SIV-infected rhesus macaques
Comorbidity of Myasthenia gravis and Graves' disease as immune reconstitution-associated autoimmune disease in HIV infection: A case report and literature review.
Distinct Binding Modes of Inter-Spike Cross-Linking Suggest a Supplementary Mechanism for SARS-CoV-2 Antibody Neutralization
Guidelines for the Prevention and Treatment of Chronic Hepatitis B (version 2022)
(5R)-5-hydroxytriptolide for HIV immunological non-responders receiving ART: a randomized, double-blinded, placebo-controlled phase II study.
Immunological changes after COVID-19 vaccination in an HIV-positive patient
Immune checkpoint inhibitor therapy for cancer patients infected with HIV: A systematic review.
HBV pgRNA profiles in Chinese HIV/HBV coinfected patients under pre- and posttreatment: a multicentre observational cohort study.
Expert Consensus on Diagnosis and Treatment of End-Stage Liver Disease Complicated with Infections
HIV-Related Immune Activation and Inflammation: Current Understanding and Strategies.
Pharmacodynamics of efavirenz 400 mg in treatment-naïve Chinese HIV-infected patients in a prospective cohort study.
Therapeutic prediction of HIV-1 DNA decay: a multicenter longitudinal cohort study.
Coagulopathy and Antiphospholipid Antibodies in Patients with Covid-19
The use of anti-inflammatory drugs in the treatment of people with severe coronavirus disease 2019 (COVID-19): The Perspectives of clinical immunologists from China
Aging in COVID-19: Vulnerability, immunity and intervention
Hypothesis for potential pathogenesis of SARS-CoV-2 infection–a review of immune changes in patients with viral pneumonia
Clinical observation and management of COVID-19 patients
High-Dose Intravenous Immunoglobulin as a Therapeutic Option for Deteriorating Patients With Coronavirus Disease 2019
[Clinical and coagulation characteristics in 7 patients with critical COVID-2019 pneumonia and acro-ischemia].
COVID-19: towards understanding of pathogenesis
Cross-reactive neutralization of SARS-CoV-2 by serum antibodies from recovered SARS patients and immunized animals.
HIV-1 CRF01_AE subtype and HIV-1 DNA level among patients with chronic HIV-1 infection: a correlation study.
Whole blood as an alternative to peripheral blood mononuclear cell for detection of total HIV-1 DNA.
Pharmacodynamics of efavirenz 400 mg in treatment-naïve Chinese HIV-infected patients in a prospective cohort study
HIV-1 CRF01_AE subtype and HIV-1 DNA level among patients with chronic HIV-1 infection: a correlation study
Therapeutic Prediction of HIV-1 DNA Decay: A Multicenter Longitudinal Cohort Study
[A randomized controlled study of peramivir, oseltamivir and placebo in patients with mild influenza].